Literature DB >> 20146721

Epitope specificity and significance in systemic autoimmune diseases.

Michael Mahler1, Marvin J Fritzler.   

Abstract

Autoimmune diseases are characterized by self-reactive immune processes mediated by B and T cells. These disorders exhibit a spectrum of clinical features that range from local or organ specific to systemic diseases. Although a variety of putative mechanisms that trigger the loss of tolerance and thus the genesis of autoimmunity have been identified, for the most part the precise mechanisms remain elusive. Nevertheless, it is widely appreciated that autoantibodies are useful both in the diagnosis of autoimmune disorders and as molecular biological tools to study cellular processes in which the target antigens are involved. Several methods and technologies, including protein fragments, synthetic peptides, phage display, or structural analyses have been developed for the characterization of the specificity of the autoimmune reactions. The present review provides an overview of the autoantibody epitopes in systemic autoimmune diseases as they relate to the clinical relevance and applications of certain autoepitopes and the technologies that are used to classify and identify them.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146721     DOI: 10.1111/j.1749-6632.2009.05127.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  34 in total

Review 1.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

2.  Clinical performance evaluation of a novel, automated chemiluminescent immunoassay, QUANTA Flash CTD Screen Plus.

Authors:  Chelsea Bentow; Gabriella Lakos; Rachel Rosenblum; Cassandra Bryant; Andrea Seaman; Michael Mahler
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 3.  Current approaches to fine mapping of antigen-antibody interactions.

Authors:  W Mark Abbott; Melissa M Damschroder; David C Lowe
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

4.  Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.

Authors:  Lisa K Peterson; Troy D Jaskowski; Maureen D Mayes; Anne E Tebo
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

5.  Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy.

Authors:  Minae Kawashima; Ling Lin; Susumu Tanaka; Poul Jennum; Stine Knudsen; Sona Nevsimalova; Giuseppe Plazzi; Emmanuel Mignot
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

6.  Mapping a Conformational Epitope of Hemagglutinin A Using Native Mass Spectrometry and Ultraviolet Photodissociation.

Authors:  M Rachel Mehaffey; Jiwon Lee; Jiwon Jung; Michael B Lanzillotti; Edwin E Escobar; Keith R Morgenstern; George Georgiou; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2020-08-12       Impact factor: 6.986

7.  MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.

Authors:  Maartje G Huijbers; Wei Zhang; Rinse Klooster; Erik H Niks; Matthew B Friese; Kirsten R Straasheijm; Peter E Thijssen; Hans Vrolijk; Jaap J Plomp; Pauline Vogels; Mario Losen; Silvère M Van der Maarel; Steven J Burden; Jan J Verschuuren
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

Review 8.  Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.

Authors:  Michael Mahler; Frederick W Miller; Marvin J Fritzler
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

9.  Lupus anti-ribosomal P autoantibody proteomes express convergent biclonal signatures.

Authors:  M A Al Kindi; A D Colella; D Beroukas; T K Chataway; T P Gordon
Journal:  Clin Exp Immunol       Date:  2016-01-29       Impact factor: 4.330

10.  Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients.

Authors:  C Pizzorni; M Cutolo; A Sulli; B Ruaro; A C Trombetta; G Ferrari; G Pesce; V Smith; S Paolino
Journal:  Clin Rheumatol       Date:  2018-07-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.